Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-04-02

Clinical Trial Update: Prediction of Inter-individual Differences in the Response to Morphine Versus Milnacipran in Patients With Sciatica [Phase 2]

View source ↗

Summary

Phase 2 trial exploring inter-individual differences in response to morphine versus milnacipran in patients with neuropathic pain (sciatica).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Milnacipran (milnacipran)
  • Morphine (morphine)

Snippet

Sponsor: Rambam Health Care Campus | Conditions: Neuropathic Pain | Phase 2 | Status: UNKNOWN